Loading…
Quoin Pharmaceuticals, Ltd. is projected to rise to $6.11 by 2027, a +22% move from its current price of $5.00. QNRX is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $4.82 | $5.00 | $5.20 | +0.10% |
| May 30 | $4.75 | $5.01 | $5.28 | +0.20% |
| May 31 | $4.70 | $5.01 | $5.35 | +0.30% |
| Jun 1 | $4.66 | $5.02 | $5.41 | +0.40% |
| Jun 2 | $4.62 | $5.02 | $5.46 | +0.50% |
| Jun 3 | $4.59 | $5.03 | $5.51 | +0.59% |
| Jun 4 | $4.56 | $5.03 | $5.56 | +0.69% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $4.56 | $5.03 | $5.56 | +0.69% |
| Week 2 | $4.41 | $5.07 | $5.83 | +1.39% |
| Week 3 | $4.30 | $5.10 | $6.06 | +2.10% |
| Week 4 | $4.21 | $5.14 | $6.27 | +2.81% |
| Week 5 | $4.15 | $5.18 | $6.46 | +3.52% |
| Week 6 | $4.09 | $5.21 | $6.65 | +4.24% |
| Week 7 | $4.04 | $5.25 | $6.82 | +4.96% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Quoin Pharmaceuticals, Ltd. is a late-stage specialty pharmaceutical company focused on the development and commercialization of therapeutic products for rare and orphan diseases in the United States. The company’s lead product is QRX003, a topical lotion in phase 2 to treat netherton syndrome, with earlier-stage and other programs in development for related conditions.
The pipeline also includes QRX008 for scleroderma in pre-clinical stage and QRX009 for microcystic lymphatic malformations and related diseases. Quoin has a research agreement with Queensland University of Technology and operates as a subsidiary of Skinvisible, Inc. The company was founded in 2018 and is based in Ashburn, Virginia.
Quoin Pharmaceuticals, Ltd. trades under the symbol QNRX. The current price is $4.77 with a market capitalization of $9.58M, and it ranks 5162 in market cap terms. The stock trades in a context of notable volatility and a bearish near-term tone.
A major floor 27.2% below — a decisive break under it would weaken the trend.
The nearest floor, 4.6% below — buyers have tended to step in here.
The nearest ceiling, 31.6% above — a clean break opens room to run.
A major ceiling 109.0% above — clearing it would confirm fresh momentum.
Key QNRX support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of QNRX market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $4.88 | Buy | $4.99 | Buy |
| MA 10 | $5.26 | Sell | $5.22 | Sell |
| MA 20 | $5.75 | Sell | $5.55 | Sell |
| MA 50 | $6.30 | Sell | $6.39 | Sell |
| MA 100 | $7.83 | Sell | $7.63 | Sell |
| MA 200 | $9.61 | Sell | $11.01 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 35.91 | Neutral |
| Stoch RSI (14) | 29.34 | Neutral |
| CCI (20) | -97.09 | Neutral |
| Williams %R (14) | -85.62 | Info |
| MACD (12,26,9) | -0.07 | Sell |
| ROC (12) | -15.68 | Sell |
| Bollinger %B (20,2) | 0.18 | Neutral |
| Stochastic %K (14) | 14.38 | Buy |
| TRIX (15) | -0.73 | Sell |
| Awesome (5,34) | -0.97 | Sell |
| Ultimate (7,14,28) | 21.94 | Buy |
| Momentum (10) | -1.07 | Sell |
| Aroon Osc (25) | -64.00 | Sell |
| Hull MA (9) | 4.67 | Buy |
| ADX (14) | 21.29 | Sell |
| ATR (14) | 0.20 | Info |
Technically, the sentiment is bearish. The RSI(14) is 30, and the stock is trading below both the SMA50 ($6.43) and SMA200 ($9.63). The current price of $4.77 sits at a defined support level of $4.77, with resistance at $6.58.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $4.77 | $5.00 | $6.72 | 0% | Neutral | |
| $4.67 | $6.11 | $8.57 | +22% | Bullish | |
| $5.05 | $6.87 | $10.09 | +37% | Bullish | |
| $4.85 | $6.82 | $10.39 | +36% | Bullish | |
| $4.12 | $5.97 | $9.37 | +19% | Neutral | |
| $4.13 | $6.14 | $9.90 | +23% | Bullish | |
| $4.15 | $6.33 | $10.46 | +27% | Bullish | |
| $4.23 | $6.61 | $11.15 | +32% | Bullish | |
| $5.24 | $8.38 | $14.43 | +68% | Bullish | |
| $5.19 | $8.49 | $14.89 | +70% | Bullish | |
| $6.16 | $11.20 | $21.18 | +124% | Bullish | |
| $6.97 | $15.31 | $32.29 | +206% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $4.77 | $5.00 | $5.89 | +0.00% |
| June 2026 | $4.32 | $5.12 | $6.23 | +2.33% |
| July 2026 | $4.57 | $5.47 | $6.79 | +6.94% |
| August 2026 | $4.51 | $5.46 | $6.87 | -0.24% |
| September 2026 | $4.29 | $5.23 | $6.65 | -4.20% |
| October 2026 | $4.32 | $5.30 | $6.81 | +1.37% |
| November 2026 | $4.36 | $5.39 | $6.99 | +1.62% |
| December 2026 | $4.14 | $5.14 | $6.72 | -4.59% |
Click any year to see its month-by-month QNRX forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, QNRX is projected to trade between $4.77 and $6.72, averaging $5.00 — a potential gain of 0% from today's $5.00. Price action looks broadly range-bound.
Quoin Pharmaceuticals, Ltd.'s 2027 outlook centres on $6.11, within a $4.67 to $8.57 range. That is up +22% on the projected 2026 average. That marks a +22% change versus current levels. Buyers look set to stay in control over this stretch.
By 2028, QNRX could reach as high as $10.09, with a base case around $6.87 and support toward $5.05 — roughly +37% from $5.00. Momentum favours further upside here.
Expect QNRX to range from $4.85 to $10.39 through 2029. The $6.82 average target implies a +36% move from current prices. That is -1% versus the projected 2028 average. Buyers look set to stay in control over this stretch.
The QNRX price prediction for 2030 points to an average of $5.97 (low $4.12, high $9.37) — a potential gain of +19% on today's $5.00. Price action looks broadly range-bound.
In 2031, QNRX is projected to trade between $4.13 and $9.90, averaging $6.14 — a potential gain of +23% from today's $5.00. That is up +3% on the projected 2030 average. Buyers look set to stay in control over this stretch.
Quoin Pharmaceuticals, Ltd.'s 2032 outlook centres on $6.33, within a $4.15 to $10.46 range. That is up +3% on the projected 2031 average. That marks a +27% change versus current levels. Momentum favours further upside here.
By 2033, QNRX could reach as high as $11.15, with a base case around $6.61 and support toward $4.23 — roughly +32% from $5.00. Buyers look set to stay in control over this stretch.
Expect QNRX to range from $5.24 to $14.43 through 2034. The $8.38 average target implies a +68% move from current prices. That is up +27% on the projected 2033 average. Momentum favours further upside here.
The QNRX price prediction for 2035 points to an average of $8.49 (low $5.19, high $14.89) — a potential gain of +70% on today's $5.00. Buyers look set to stay in control over this stretch.
In 2040, QNRX is projected to trade between $6.16 and $21.18, averaging $11.20 — a potential gain of +124% from today's $5.00. That is up +32% on the projected 2035 average. Momentum favours further upside here.
Quoin Pharmaceuticals, Ltd.'s 2050 outlook centres on $15.31, within a $6.97 to $32.29 range. That is up +37% on the projected 2040 average. That marks a +206% change versus current levels. Buyers look set to stay in control over this stretch.
Investing $1,000 in QNRX today (≈ 200 QNRX) could be worth
$3,062.9
+$2,062.9 (+206%) by 2050 · US Dollar
Based on the average projected QNRX price of $15.31 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in QNRXwould be worth at today's price.
$1,000 invested in QNRX on May 27, 2025 (≈ 101.419882 QNRX) would be worth
$507.1
-$492.9 (-49.3%) today · 0.51× · US Dollar
Based on a QNRX entry price of $9.86 vs. today's $5.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $4.94 | $1,012.15 | +1.2% |
| 1 month ago | $5.46 | $915.75 | -8.4% |
| 3 months ago | $8.51 | $587.54 | -41.2% |
| 6 months ago | $21.75 | $229.89 | -77.0% |
| 1 year ago | $9.86 | $507.1 | -49.3% |
| All time (5.0y) ago | $68,670 | $0.07 | -100.0% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our QNRX forecast.
Our base-case forecast reaches $10.00 around 2040.
Implied market cap at $10.00: $20.08M
The multi-year forecast shows a bullish trend after 2026, with yearly averages and ROI varying by year. 2026 delivers an average of $4.77 with a max of $6.40 and 0% ROI; 2027 shows an average of $5.95 with a max of $8.39 and 24.7% ROI; 2028 shows an average of $6.62 with a max of $9.80 and 38.8% ROI; 2029 shows an average of $6.51 with a max of $10.00 and 36.4% ROI. By 2030 the average is $5.75 (min $3.93, max $9.12) with 20.6% ROI, and by 2031–2032 the averages progress to $5.88 and $6.03 respectively with ROIs of 23.2% and 26.3%.
In 2033 the average is $6.38 (max $10.88) with 33.7% ROI; 2034 shows $8.07 as the average and $14.06 as the max with 69.2% ROI; 2035 shows $8.16 average and $14.48 max with 71.1% ROI. The path continues to 2040 with an average of $10.82 and max of $20.75 (126.9% ROI) and culminates in 2050 at an average of $14.53 with a max of $31.13 (204.5% ROI). The forecast assigns a bullish sentiment to most years after 2026, though these figures are estimates and not guarantees.
Tap a question to reveal the answer.
In 2030 the forecast shows an average price of $5.75, with a minimum of $3.93 and a maximum of $9.12, and a predicted ROI of 20.6%. The sentiment for 2030 is bullish.
The forecasted path from 2027 onward is bullish, with rising averages and positive ROIs (e.g., 2027 ROI 24.7%, 2028 ROI 38.8%, 2029 ROI 36.4%, and 2050 ROI 204.5%). However, 2026 is neutral and the figures are estimates, not guarantees.
Yes. The year 2033 shows a max forecast of $10.88 and 2034 shows a max forecast of $14.06, with the 2035 max at $14.48, indicating $10 is within the projected range in multiple years.
The near-term outlook is bearish with a current price at $4.77 and a RSI of 30, and it trades below key moving averages. The forecasted path is conditional on multiple factors and carries typical market and regulatory risks; the results are not guaranteed.
The 2050 forecast shows an average price of $14.53 and a maximum of $31.13, with a predicted ROI of 204.5%.
Quoin Pharmaceuticals, Ltd. Community Discussion
0Share your Quoin Pharmaceuticals, Ltd. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.